- Home
- PBH vs MBLY Comparison
PBH vs MBLY Comparison
Compare PBH & MBLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBH | MBLY |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 6.8B |
| IPO Year | 2004 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PBH | MBLY |
|---|---|---|
| Price | $61.32 | $7.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 19 |
| Target Price | ★ $80.75 | $16.17 |
| AVG Volume (30 Days) | 361.9K | ★ 3.9M |
| Earning Date | 05-07-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.88 | ★ 87.43 |
| EPS | ★ 2.78 | N/A |
| Revenue | $975,777,000.00 | ★ $1,894,000,000.00 |
| Revenue This Year | N/A | $4.91 |
| Revenue Next Year | $2.15 | $14.09 |
| P/E Ratio | $22.30 | ★ N/A |
| Revenue Growth | ★ 36.77 | 14.51 |
| 52 Week Low | $57.25 | $7.58 |
| 52 Week High | $88.55 | $20.18 |
Technical Indicators
Market Signals| Indicator | PBH | MBLY |
|---|---|---|
| Relative Strength Index (RSI) | 28.88 | 26.10 |
| Support Level | $60.75 | N/A |
| Resistance Level | $63.26 | $9.74 |
| Average True Range (ATR) | 1.83 | 0.28 |
| MACD | -0.97 | -0.04 |
| Stochastic Oscillator | 1.41 | 2.49 |
Price Performance
Historical ComparisonAbout PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Moovit. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.